# ADHD Medication and Predictors of Treatment Outcome

> **NCT02136147** · — · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 632 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity (ADHD)

## Interventions

- **DRUG:** methylphenidate medication
- **DRUG:** atomoxetine medication
- **DRUG:** lisdexamphetamine medication
- **DRUG:** guanfacine medication

## Key facts

- **NCT ID:** NCT02136147
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2021-07
- **Final completion:** 2022-06
- **Target enrollment:** 632 (ACTUAL)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02136147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02136147, "ADHD Medication and Predictors of Treatment Outcome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02136147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*